Reciprocating Dissolution Apparatus Bead Mechanical Stress
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current dissolution testing methods for active pharmaceutical ingredients (APIs), particularly those with low solubility in extended release dosage forms, fail to accurately predict in vivo performance due to poor mimicry of gastrointestinal conditions, leading to incomplete and unreliable release kinetics.
Innovation Solution
A dissolution testing apparatus and process that utilizes beads with a density of 1.1 g/ml to 1.5 g/ml to reciprocate the dosage form within the testing media, inducing mechanical stress and simulating physiological conditions, thereby enhancing the erosion of the polymer matrix and release of the API.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If standardized pharmacopeial dissolution testing is used, then testing conditions are highly standardized and reproducible, but predictive value for in vivo dissolution variability is poor
Solution Approach 1:
The invention changes the physical parameters of the dissolution test by introducing beads with specific density (1.05-1.20 g/cm³) and size (4-8 mm) to create mechanical stress on the dosage form. This modifies the testing conditions from static pharmacopeial methods to a dynamic system that simulates gastrointestinal mechanical forces, thereby improving in vivo predictability while maintaining reproducibility through controlled bead characteristics
2Duration of action of moving object
If hydrophilic matrix is used in extended release dosage form, then controlled release is achieved, but polymer gel layer formation prevents API release in low solubility APIs
Solution Approach 1:
The invention applies mechanical stress through reciprocating motion of the dosage form against beads, creating friction and erosion forces that break down the polymer gel layer. This mechanical action enhances API release from the hydrophilic matrix by preventing gel layer accumulation, thereby maintaining controlled release duration while improving release rate for low solubility APIs
3Productivity
If mechanical stress is applied to break matrices, then API dissolution is improved, but manual intervention is required and errors increase
Solution Approach 1:
The invention creates a self-operating system where the dissolution apparatus automatically reciprocates the dosage form against beads without manual intervention. The mechanical stress application is automated through the apparatus design, eliminating the need for manual matrix breaking while maintaining consistent dissolution efficiency and reducing human error
4Reliability
If beads with density 1.05 g/cm³ to 1.20 g/cm³ are used, then mechanical stress is induced and in vivo predictability is improved, but device complexity increases
Solution Approach 1:
The invention designs the dissolution apparatus to perform multiple functions: standard dissolution testing, mechanical stress application through bead interaction, and simulation of gastrointestinal forces. The beads serve dual purposes as both dissolution media components and mechanical stressors, while the reciprocating mechanism integrates both agitation and erosion functions, reducing overall system complexity despite enhanced capabilities
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a reliable prediction of in vivo dissolution for APIs with low solubility, improving the correlation between in vitro and in vivo results by continuously applying mechanical stress without manual intervention, reducing errors, and facilitating faster API release comparable to gastrointestinal conditions.
Implementation Method 1
capable of inducing mechanical stress to the dosage form while the apparatus is in operation
Implementation Method 2
The API is released considerably only after the swollen gel layer erodes. Clearly the polymer matrix erosion contributes substantially to overall release kinetics. In vivo erosion of the dosage form is affected by different hydrodynamic conditions, shear stress and friction forces in gastrointestinal tract
Implementation Method 3
hydrophilic matrix forms a polymeric gel layer immediately after the dosage form gets in contact with the surrounding media
Implementation Method 4
API with low solubility can not be instantly released from the extended release dosage form comprising a hydrophilic matrix when exposed to the aqueous media
Data Source
Figure 1
Figure 2~3
Figure 4~5
AI summary
The present invention relates to a concept for testing dissolution of an active pharmaceutical ingredient in an apparatus capable of reciprocating a dosage form up and down in a testing media in combination with beads comprising a density of 1.1 g/ml to 1.5 g/ml.